A New England Journal of Medicine (NEJM) study published in 2021 shows a weight loss breakthrough. They used a medication called Semaglutide, which is a Glucagon-like peptide-1 (GLP-1) analogue that's already used to treat Type 2 Diabetes and got some unbelievable weight loss results
Thanks for watching, I hope you enjoyed the content and found it genuinely useful.
Please consider supporting the channel by signing up to Patreon:
https://www.patreon.com/bradstanfieldmd
My supplement stack: https://drstanfield.com/pages/my-supplements/
The other supplements I take are found here:
http://amzn.to/3o2ULOV
Join me over on Twitter:
https://twitter.com/BradStanfieldMD
Here are the links to the research papers referenced in the video:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764193/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617638/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787121/
https://pubmed.ncbi.nlm.nih.gov/33567185/
https://pubmed.ncbi.nlm.nih.gov/33567185/
If you like this video please smash the thumbs up button, it really helps with the Youtube algorithm :-)
#WeightLoss #Breakthrough #GLP1
The links above are affiliate links, so I receive a small commission every time you use them to purchase a product. The content contained in this video, and its accompanying description, is not intended to replace viewers’ relationships with their own medical practitioner. Always speak with your doctor regarding the content of this channel, and especially before using any products, services, or devices discussed on this channel.
Netscribes is a global data, insights and digital fulfilment firm